1. Home
  2. MDGL vs QNT Comparison

MDGL vs QNT Comparison

Compare MDGL & QNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$519.09

Market Cap

12.8B

Sector

Health Care

ML Signal

HOLD

QNT

Quantinuum Inc. Class A Common Stock

N/A

Current Price

$55.24

Market Cap

15.1B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
MDGL
QNT
Founded
2011
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
12.8B
15.1B
IPO Year
2005
2026

Fundamental Metrics

Financial Performance
Metric
MDGL
QNT
Price
$519.09
$55.24
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
$674.45
N/A
AVG Volume (30 Days)
372.3K
1.5M
Earning Date
05-06-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$180,133,000.00
N/A
Revenue This Year
$58.39
N/A
Revenue Next Year
$48.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$393.61
$47.06
52 Week High
$615.00
$86.79

Technical Indicators

Market Signals
Indicator
MDGL
QNT
Relative Strength Index (RSI) 50.90 44.31
Support Level $498.59 $51.22
Resistance Level $545.13 $72.40
Average True Range (ATR) 19.22 5.46
MACD 1.86 0.23
Stochastic Oscillator 76.90 22.94

Price Performance

Historical Comparison
MDGL
QNT

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: